Blog

Mike Bertke

Mike Bertke is an Associate at F-Prime, focusing on investments in healthcare technology and service companies. Prior to joining F-Prime, he worked at RBC Capital Markets, where he advised the nation’s leading health systems on debt capital markets and M&A transactions. Before that, Mike also worked in intellectual property valuation at Aon.

Mike holds a B.A. from Villanova University, where he majored in Economics.

Flourish Health

Flourish Health is a mental health provider for young people with serious, complex needs that traditional care models cannot effectively support. Through a unique, in-home care model with psychiatrist-led teams and proprietary AI, Flourish Health improves the wellbeing of children and young adults with serious mental health needs while substantially reducing hospitalizations and residential treatment. Flourish Health works with major health plans to support families navigating complex needs including depression, anxiety, bipolar disorder, trauma-related conditions, and disruptive, impulse-control and conduct disorders.

Marit Health

Marit Health is the fastest-growing AI-powered platform and clinician community in medicine. Launched in 2025 by clinicians and former Glassdoor executives, Marit gives physicians and advanced practice providers (APPs) the information and tools they need to thrive in their careers. Marit is the top AI-powered jobs platform for clinicians and has the most comprehensive clinician-reported real-time salary intelligence platform, including industry compensation benchmarks from MGMA and AMGA.

Behind the Breakthrough: Q&A with AJ Loiacono, Chief Executive Officer of Judi Health

Twenty-six years ago, AJ Loiacono was a consultant helping pharmaceutical manufacturers upgrade their supply chain systems. He assumed drugs made it to consumers at a fair price. Then a friend handed him a claims file—and his entire perspective on the industry changed.

What Loiacono discovered was a pattern of inefficiency so widespread that it revealed deep structural challenges within the system: drug prices fluctuating hourly, vendors duplicating and distorting claims data, and an industry built on misaligned incentives and conflicts of interest rather than patient outcomes. After eight years auditing pharmacy benefit manager (PBM) contracts and watching the industry resist reform, he reached a conclusion: to fix the system, one had to become part of it – and rebuild it from scratch.

In 2017, AJ co-founded Capital Rx on two principles that ran counter to industry norms: never profit from drug spend and build technology so efficient it could sustain a business without hidden fees. Today, Judi Health manages care and processes claims for over 58 million covered lives, maintains a 99% client retention rate, and is setting a new standard for what healthcare administration can look like when built on transparency and technology rather than complexity and conflict.

You spent years auditing PBM contracts before founding your own company. What made you decide to build rather than continue to consult?

What I realized is that change was slow to materialize. The dominant PBMs in the industry had established ways of operating that seemed generally, albeit reluctantly, accepted, and meaningful innovation in the business model seemed elusive at the time.

I felt the only way to really move the industry in the appropriate direction was to first become part of the problem. I would need to become a PBM. And I would start a company based upon two principles: one, our incentives as an administrator would never conflict with the cost of medications. And two, we would operate more efficiently than our competitors and put plan members first, so we built a hyper-efficient technology platform that allows us to administer claims approximately 70% more efficiently than competitors.

Why is the “no profit on drug spend” principle so foundational for both a transparent PBM and what you’re building?

In our view, it’s paramount to align incentives in pharmacy benefit management so the administrator’s sources of revenue and interests are fully transparent and in step with the plan and its members. When organizations generate revenue based on the amount spent on medications, it can create competing priorities.

Our approach is to ensure that our earnings are independent of drug costs, allowing us to focus squarely on delivering value and removing any potential for misaligned incentives. This principle echoes back to earlier eras in our industry, when PBMs primarily served as service providers rather than as intermediaries capturing multiple revenue streams from each transaction.

Over time, the industry has evolved. Many organizations have expanded their portfolios to cover everything from health plans and provider networks to mail order and specialty pharmacy services. While this vertical integration created efficiencies in some areas, it also introduced new complexities and new models for compensation. Our founding principle is to keep things straightforward and transparent, reinforcing trust for everyone involved.

You’ve built something called “Unified Claims Processing.” What problem does it solve?

Processing a healthcare claim can be complex, often involving many different stakeholders. These include providers, health plans, third-party vendors, and members themselves – each of whom needs clear, timely information. Traditionally, the flow of a claim is supported by a series of systems and vendors, each responsible for different parts of the workflow, whether the claim concerns medical, pharmacy, dental, or vision benefits.

As claims travel between systems, updates and changes can occur rapidly – claims may be paid, adjusted, or re-coded in real time, making it challenging to ensure that everyone is always working from the same set of facts. With this in mind, we saw an opportunity to build a unified system that brings together all the moving parts of the claims process, providing a single source of truth and reducing unnecessary administrative complexity.

We realized, if we could be the first company to build Unified Claims Processing, we would reduce cost by reducing overhead and administrative inefficiencies. We aim to streamline the entire experience for patients, providers, and plan sponsors – helping to control costs, minimize redundancies, and ultimately make the healthcare journey simpler and more transparent for all.

Can you share an example of the kind of confusion Unified Claims Processing is designed to solve?

I’ll share a story that illustrates the challenges here. An investor of ours – a highly educated professional – recently experienced some confusion after returning to work following the birth of her child. She received a bill from the hospital for her care, followed by a different amount from her insurance carrier, and then a third, different, figure from a separate payment integrity company. Despite her very knowledgeable background, even she found it difficult to reconcile these numbers, leaving her wondering how anyone could confidently navigate the process.

What often happens is that different organizations involved in the same episode of care are referencing slightly different versions of the same claim information at different points in time. This can lead to confusion for patients, frustration for providers, and additional administrative work for health plans.

That is exactly what Unified Claims Processing solves. It is one system, one source of truth, in real time.

How do you measure real-world impact?

For us, real-world impact starts with delivering cost savings for our clients. Many of the organizations we serve are sizable – on average, our clients’ plans cover around 20,000 lives. Achieving meaningful savings is imperative not just at the outset, but continually over the life of our partnership.

We are most proud to have supported long-term clients who have seen flat or even negative trends in their overall pharmacy spend, even as healthcare costs elsewhere in the US continue to rise year-over-year. Long-term cost containment is essential, especially when compounding can quickly double expenses.

Beyond the numbers, we put a strong emphasis on service. Our dedicated, in-house call center team, all full-time employees based in the US, helps ensure responsive, personal support. This commitment is reflected in the routinely high customer satisfaction scores our call center receives, as well as our 99% client retention rate.

Ultimately, our two most important measures of success are straightforward: clients who achieve sustainable savings, and members who are satisfied and well-supported in their healthcare journey.

What drives you to take on such an ambitious challenge in healthcare?

The scale of what we’re working on makes the mission even more meaningful. The broader and more complex the challenge, the greater the potential to improve outcomes across the system. I sometimes say this isn’t just a moonshot – it’s more like a Mars shot. Aiming even higher to create true, lasting impact in healthcare.

I also want people to understand who is hit hardest by inflation on drug spend or healthcare in general. It’s the most vulnerable parts of our population – the elderly and people who have lower incomes. This is not what healthcare should be. That’s precisely what keeps us focused on the mission at hand.

What are the most critical milestones for Judi Health in the next 12 to 24 months?

When developing Unified Claims Processing, we believed it was important to start close to home – so our first implementation was for our own employees and their families. Seeing firsthand how much our team appreciated the ease and clarity of this benefit gave us confidence to extend the offering to clients.

Within the first six months, we’ve welcomed both existing and new clients who are now using the platform for both pharmacy and medical administration. Their positive feedback has reinforced our conviction that a streamlined, unified system delivers real value.

Looking ahead, our ambitious goal is to help make Unified Claims Processing the new industry standard – where medical, pharmacy, dental, vision benefits, accumulators, and eligibility are all accessible in one place and in real time. Once organizations and members experience this level of integration and transparency, it’s hard to go back.

Ultimately, our mission is to help build the modern infrastructure that healthcare in this country deserves. True transformation depends on updating the foundational systems, and we’re committed to helping lead the way forward.

Behind the Breakthrough: Q&A with Chris Johnson, Founder and CEO of Bluebird Kids Health

After helping advance value-based care for older adults as the CEO of Landmark Health, Johnson saw an opportunity to bring a similar model to children: a value-based pediatric primary care platform.

Bluebird Kids Health was born from a stark realization for CEO Chris Johnson: nearly half of America’s children receive care through Medicaid or CHIP, but many live in what he calls “pediatric care deserts” – communities where kids are far more likely to end up in the ER, because they can’t easily access primary care.

Johnson discusses why he’s bringing value-based care to pediatrics and how Bluebird is confronting structural inequities in children’s health. He also explores what it means to build a company designed not just to treat illness, but to help every child reach their full potential through equitable health care – one community at a time.

Was there a defining moment that crystalized the need for Bluebird?

Across metro areas, the lowest-income communities have only half as many pediatricians per thousand children as the highest-income zip codes. Many practices can only afford to have around 20% of their patients on Medicaid, which creates barriers to preventative care for millions of children. We set out to close that gap with an integrated model that brings physical, behavioral, and social services under one roof. Bluebird uses technology to make care more consistent and scalable, while aligning patient outcomes with payer incentives and reinvesting to expand services in pediatric care deserts.

Your mission statement is “to provide exceptional care so all children can thrive.” What does that look like day by day?

For us, exceptional care begins by giving our providers the support they need to practice at the peak of their ability. We invest in training, technology, and team-based support, allowing providers to focus on families and not paperwork. It means partnering with behavioral health providers and community organizations to fill social care needs that fall outside traditional medicine.

The “Every Child” aspect means we never want to turn away a child who comes to our door.  We contract with all health plans and offer a self-pay option to ensure every family can access care. We identify primary care deserts by running analytics to pinpoint areas where children have limited access to pediatric practices. In areas with the greatest need, we open clinics in retail spaces (e.g., near grocery stores or laundromats) to meet families “in the flow” of daily life, with extended evening and weekend hours.

Finally, “so all children can thrive” is our long-term measure of success. We aim to create more happy, healthy days for kids. It’s not just about clinical outcomes. It’s about helping children stay in school because they’re now getting the care they need or catching vision issues early to support them as they learn to read. Ultimately, it is about building the foundation for lifelong health.

You brought value-based care principles from adulthood into pediatrics. Why hasn’t this been done before – and why now?

Sometimes problems persist simply because no one has really focused on them. In 1987, only about 16% of children in the U.S. were covered by Medicaid; today, that number exceeds 50%. That means more than half of America’s pediatric population now relies on a system that has historically lacked the innovation and coordinated care models seen in adult medicine. Millions of children still face inequitable access despite having insurance coverage. It’s a massive and growing need, and it’s time the innovation ecosystem caught up to it.

You applied lessons from Landmark Health to this new model. What are some of the biggest takeaways?

The biggest lesson was that you need a mission-aligned culture that truly believes in doing what’s right for patients, paired with a business model that rewards it. When those align, everything else follows.

We’ve also leaned heavily into technology and AI at Bluebird. At Landmark, we used technology because we had to, mainly to process claims and manage data. At Bluebird, we see technology as a driver of the experience itself. We’re building what we call a “pediatric operating system,” which is AI-enabled infrastructure made specifically for this population. It makes back-end operations more efficient and the front-end experience more consistent, from the parent app to the clinical workflow.

What’s your approach to growth, and where do you go from here?

We’re currently operating six Bluebird clinics and expect several more by year’s end. We plan to continue expanding in Florida, then into new states. Our goal is to go deep and truly integrate into communities. In a place like Tampa, for example, we’d rather build half a dozen practices so we can truly serve as a meaningful part of the local health infrastructure and be a reliable partner to hospitals and OBs. Instead of opening a single location in many markets, we focus on building multiple practices within a city so we can become embedded in the community and part of the local health ecosystem.

You’ve mentioned technology as a differentiator. How is AI changing your model?

We use AI to streamline areas across the organization. Things like scheduling, insurance verification, and revenue cycle management become far more efficient with AI, allowing our teams to focus more time and energy on patients. On the care side, we leverage data and analytics to identify children who need proactive interventions, such as closing preventive care gaps. We are also designing digital care management tools that support parents at home.

The key for successfully using AI is integrating it intelligently into the workflow to actually drive outcomes, which is what we’re building our systems to do.

Looking ahead to 2030, what impact do you hope Bluebird will have?

Our north star is to be a meaningful contributor to the health and well-being of children in every community we enter. If you look at why the U.S. lags other wealthy countries in life expectancy, most of that gap actually stems from outcomes for people under 18.

We want to help change that trajectory by reducing preventable mortality, improving health equity, and supporting children as they grow into healthy adults. That’s what “so all children can thrive” truly means for us.

Almanac Health

Almanac Health is a clinical AI platform that brings specialist-grade knowledge to clinicians at the point of care — providing evidence-based clinical decision support across medical specialties, free from pharmaceutical advertising, and governed by institutional controls. The platform integrates with existing EHR systems and is clinically validated through peer-reviewed research. Almanac Health was founded by Cyril Zakka, MD, author of one of NEJM AI’s most-cited papers on retrieval-augmented generation for clinical medicine.

Alder

Alder offers expert, hands-on support for families navigating the complexities of aging. Alder is a team of experienced social workers and nurses helping families navigate the complexities of aging with compassion, clarity, and hands-on support.

Nikhil Marathe

Nikhil is a Principal at F-Prime, where he spearheads the firm’s efforts in venture growth. His primary focus is to partner with rapidly growing, capital efficient businesses in healthcare software and services.

Prior to joining F-Prime, Nikhil worked at Juxtapose, a creation-oriented investment firm focused on healthcare and technology, where he spent 2 years incubating a new business venture in the pharmaceutical services ecosystem. Prior to Juxtapose, Nikhil spent 13 years at Silversmith Capital Partners and TA Associates, where he closed 12 growth-stage investments across healthcare and enterprise software. He began his career as a technology investment banker at Evercore.

Nikhil has a BS in Economics from The Wharton School at the University of Pennsylvania, with concentrations in Finance and Management.

Behind the Breakthrough: Q&A with Kai Eberhardt, CEO and Co-founder of Oviva

Kai Eberhardt transformed a personal cancer diagnosis in his twenties into a lifelong commitment to improving patient empowerment and healthcare accessibility.

Diagnosed with cancer in his early twenties, Kai Eberhardt quickly learned how disheartening it can feel to navigate the healthcare system without information or agency. That experience became a transformational force, first pushing him toward deeper medical knowledge, then through a PhD in medical physics, and ultimately into the business of healthcare.

He co-founded Oviva in 2014 with engineer Manuel Baumann to confront one of the most widespread, but underserved, health challenges in society: chronic weight-related conditions (such as obesity and type 2 diabetes). Despite the abundance of clinical evidence showing that behavior change and lifestyle interventions can be highly effective, few systems were designed to deliver them at scale, and even fewer offered sustained, patient-centric care accessible to everyday lives.

Eberhardt and his team saw an opportunity to reimagine care delivery, starting with something simple: a secure, compliant chat app connecting patients and their care teams. Over time, that communication layer evolved into Oviva’s full-stack digital care platform, now used by more than one million patients across the UK and Europe.

On the heels of Oviva’s expansion into cardio-metabolic conditions, and after nearly a decade of building credibility and capability in systems like the National Health Service (NHS), Eberhardt shares what it takes to turn frustration into innovation, how the company is scaling with purpose, and why technology is only one part of the solution.

What gap in the healthcare system were you aiming to address in founding Oviva?

The idea for Oviva emerged from a common challenge in obesity treatment—most patients don’t continue treatment after one or two visits. It just isn’t practical for patients to regularly attend sessions in-person despite a demand for care.

What stood out was that these same patients were always on their phones, and unlike other areas of care, weight management doesn’t require physical exams, lab work, or imaging. It largely includes education, coaching, and real-time support. So, we asked: what if we digitized the same care that we provided in-person and delivered it on their phones, anytime, anywhere? That would make it dramatically more accessible, and likely more effective, too.

Can you talk more about how this model helps address affordability and equity?

People managing chronic conditions often juggle jobs, childcare, daily stress – and weight-related health is important, but not always urgent. That makes it easy to de-prioritize care, especially when it requires a visit to a doctor’s office on a random Wednesday afternoon.

Making care available on your phone, on your own schedule, changes everything. For example, look at the NHS Diabetes Prevention Programme – about 20% of people completed the in-person model, but closer to 70% completed Oviva’s digital version. That’s a massive difference.

Virtual care also opens the door to serving culturally and linguistically diverse communities. With digital delivery, you can tailor the content, language, and nutrition guidance for many different patients.  Curating care is almost impossible to do well in a one-size-fits-all, in-person group setting.

You integrate clinical, nutritional, and psychological care. What makes that approach so essential?

Obesity is multifactorial – you just can’t treat it through one lens. Some people need help with nutrition education, some have complex psychological patterns or trauma, and now we also have powerful medications that should be managed by doctors. No one discipline can cover it all.

Not every patient needs every service, but having a full stack available is essential to delivering effective care. We learned this from the best in-person programs –where coordination across teams made all the difference, though it was resource-intensive and hard to sustain. By operating digitally, we can bring those same multidisciplinary perspectives together without the limits of geography or scheduling.

What makes Oviva truly different from other players in your space?

We’re with our patients every day. That’s the biggest difference. Face-to-face models might give you 30 minutes with a clinician once a month. We’re a daily companion – logging meals, giving feedback, coaching, and support throughout the day. That consistency leads to better outcomes.

We’ve published more than 90 papers showing that we outperform in-person care, and because we’re digital, we can do it at lower cost and with broader reach. We’re essentially industrializing something that used to be artisanal – making personalized, behavior-change therapy highly scalable.

Regarding Oviva’s role within the NHS – what does it take to build innovation and credibility in a system as rigorous and complex as that one?

Evidence, first and foremost. I’ve always believed in backing up what we do with strong data, while publishing results publicly to build trust and demonstrate transparency.

After that, it’s about communication – having the skills and patience to speak to very different stakeholders across the NHS. And finally, it’s about partnership. We don’t try to replace services; we instead think about how we can add value to the system through better access and efficiency. This mindset helps us prove we’re here for the long haul.

You have talked about being driven by your own personal experiences in the healthcare space. Can you share how that energy helped shape your journey as a founder?

I’ve always been a pretty intense and action-oriented person. Frustration, for me, serves as a powerful motivator because it offers clarity and urgency. I don’t sit still when I see something broken. I’m not afraid to make decisions or move fast. I think that drive helped me do something many would consider irrational – starting a health tech company from the ground up in a pretty complex space.

Obesity is a field that often carries judgment or stigma. How do you lead with compassion and evidence in that environment?

Honestly, that’s one of the most fulfilling parts of what we do. Many of our patients haven’t received good care before – they’ve been judged or dismissed by the system. When we help them see real progress, it’s incredibly rewarding.

It’s not just for the patient’s benefit either. We’ve shown, with data, that our program reduces patient sick days by about a third within six months. That translates to added productivity in the workplace, tax revenue, and long-term cost savings – things that help the entire system. So, when people ask if this population is “worth investing in,” our results make the answer abundantly clear.

What advice would you give to other founders trying to build something in or alongside a public health system?

You need grit. It takes a long time to get through validation, adoption, and scaling inside a system like the NHS. The process can be very frustrating, especially when you know your solution could help people immediately, but adoption takes time.

Some delays are for good reasons, like needing strong evidence. Other delays are due to competing interests or systemic inertia. You must keep showing up and pushing forward. The reward is that once you’re in, and your model works, it’s incredibly sticky and impactful.

What excites you the most about what’s coming next?

We’re about to launch our hypertension solution, pending final regulatory approvals. It’s been in the works for two years and is a huge opportunity to build something that serves both patients and doctors more effectively – especially in how we manage data, daily insights, and ongoing support between visits.

The role of AI in all of this is just getting started. Our AI-first care model has the potential to transform patient support, making delivery more efficient and effective. We can provide even better continuity of care between doctor visits and better inform doctors for those visits. Since the ChatGPT moment, we’ve been embedding more AI features into our product, making care more scalable and improving outcomes. AI technology and Oviva are evolving rapidly – and I can’t wait to see how far we can go.

Olivia Carlson

Olivia Carlson is a Senior Associate at F-Prime, focusing on investments in healthcare technology and services companies. Prior to joining F-Prime, she was an investor at M33 Growth, where she assessed investment opportunities and supported their portfolio of growth-stage healthcare companies. Olivia also worked in strategy consulting for EY-Parthenon’s healthcare team. She started her career as a certified nursing assistant, working for a home health and hospice company throughout college.

Olivia holds a B.A. from Williams College, where she majored in Pre-Medical Studies and Psychology.